Skip to main content
Home » Eyeglasses & Contacts » Contact Lenses » CooperVision® MiSight® 1 day

CooperVision® MiSight® 1 day

MiSight Header.jpg

A Closer Look at Your Child’s Distance Vision

What can you do when your child tells you they’re struggling to see the board at school? Or that things are beginning to look blurrier the further they get from them? One cause for this blurry distance vision could be myopia. Myopia causes light rays to focus at a point in front of the retina rather than directly on the surface, owing to the elongation of the eye.

Even children with fairly low prescriptions have a higher risk of glaucoma and retinal detachment compared to non-myopic children, and that risk multiplies as their prescriptions get stronger.1

Focusing on Your Child’s Vision, Now and In the Future

Myopic progression is when prescriptions increase over time, and higher prescriptions have been linked to sight-threatening conditions later in life such as glaucoma, retinal detachment, and myopic maculopathy.2

Generally, myopia first occurs in school-age children and progresses until about age 203.

According to the American Optometric Association, 34% of children ages 12-17 are myopic. This is due in part to changing lifestyles, with children spending less time outdoors and more time focusing on close objects like digital screens.

Introducing MiSight® 1 Day From Cooper Vision®


The cornerstone of a comprehensive myopia management approach, MiSight® 1 day is a daily wear, single-use contact lens that has been clinically proven and FDA-approved to slow the progression of myopia (nearsightedness) when initially prescribed for children 8-12 years old.*

Know the Myopia Statistics


Myopia in children increases when both parents are myopic. The likelihood of children developing myopia is:

1 in 2

1 in 2

when both parents are myopic

1 in 3

1 in 3

when one parent is myopic

1 in 4

1 in 4

when neither parent is myopic

*Indications for Use: MiSight® (omafilcon A) daily wear single use Soft Contact Lenses are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
**Based on a clinical study in which participants were between the ages of 8 and 12 at initial fit.

1. Xu L, et al. High myopia and Glaucoma susceptibility for the Beijing Eye Study. Ophthalmology. 2007;114(2):216-20. 2. Bourne RR, et al. Causes of vision loss worldwide, 1990-2010: a systemic analysis. Lancet Glob Health. 2013;1(6):e339-49. 3. Yu L, et al. Epidemiology, genetics and treatments for myopia. Int J Ophthalmol. 2011;4(6):658-69.

CLICK HERE TO VIEW OUR CURRENT OFFICE UPDATES AND POLICIES REGARDING COVID-19